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Abstract
Replicability is a fundamental quality of scientific discoveries: we are interested in those
signals that are detectable in different laboratories, study populations, across time etc. Testing
a partial conjunction (PC) hypothesis is a statistical procedure aimed specifically to identify
the signals that are independently discovered in multiple studies, unlike meta-analysis which
accounts for experimental variability but does not require for an effect to be significantly
detected multiple times. In many contemporary applications, ex. high-throughput genetics
experiments, a large number M of partial conjunction hypotheses are tested simultaneously,
calling for a multiple comparison correction. However, standard multiple testing adjustments
for the M individual partial conjunction p-values can be severely conservative, especially when
M is large and the signal is sparse. This is due to the fact that partial conjunction is a com-
posite null. We introduce AdaFilter, a new multiple testing procedure that increases power by
adaptively filtering out unlikely candidates of partial conjunction hypotheses. We show that
the simultaneous error rates can be controlled as long as data across studies are independent.
We find that AdaFilter has much higher power than unfiltered partial conjunction tests and an
empirical Bayes method (repfdr). We illustrate the application of the AdaFilter procedures
on microarray studies of Duchenne muscular dystrophy and on GWAS for metabolomics.
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1 Introduction
Replication is “the cornerstone of science” [23]. An important scientific finding should be supported
by further evidence from other studies, by other researchers and in other laboratories. In the last
decade, however, both the popular [20] and the scientific press [4, 2] have reported on the lack
of replicability of modern research results. The National Academy of Sciences has identified this
reproducibility crisis as a major focus area.
While there are many reasons behind the lack of replicability, one important factor is that many
scientific discoveries are obtained from complicated large-scale experiments where biases can be
introduced from various sources. Even when the data analysis is carefully performed, idiosyncratic
aspects of any single experiment can fail to extend to other settings. That is, a finding in just one
experiment can easily lack external validity. Thus, it is crucial to have a statistical framework to
objectively and precisely evaluate the consistency of scientific discoveries across multiple studies,
while properly accounting for experimental and sampling heterogeneity.
The partial conjunction (PC) test was introduced by [13] and further studied in [5]. Given
n related null hypotheses (base hypotheses) and a number r ∈ {2, 3, . . . , n}, the PC null states
that fewer than r of the base hypotheses are false. One rejects the PC null hypothesis when one
is confident that r or more of the base hypotheses are false. For r ≥ 2, rejecting the PC null
explicitly guarantees that the signal is significant more than once. Like the significance level, the
replicability level r is a pre-determined number, depending on the researcher’s preference.
In high-throughput experiments, such as microarrays, RNA sequencing, genome-wide associa-
tion studies (GWAS) and eQTL (expression quantitative trait loci), it is common to test thousands
or even millions of hypotheses in one study. We let M denote this number of hypotheses. Now
suppose that there are n related high-throughput studies on this same set of M hypotheses. There
are then M PC hypotheses to test, each with n base hypotheses, one per study. We face a PC
testing issue over n base hypotheses as well as a multiple hypothesis testing issue over M PC tests.
The above framework gives us an n×M matrix of p-values, with one column per PC hypothesis
and one row per study. We might then use PC methods to get a PC p-value for each column and
apply a standard multiple testing adjustment to the M results. This simple strategy has been
shown to have low power [16, 28]. Both [16] and [8] suggest procedures to counter that power
loss. Unfortunately, [8] is designed only for n = r = 2 and the empirical Bayes approach in [16]
encounters computational difficulties for large n. There is thus a need for a powerful method that
can handle larger n.
In this paper, we introduce AdaFilter, an adaptive filtering procedure for PC hypotheses.
AdaFilter easily handles large n. The cost grows as O(Mn log(n)) from sorting base p-values
whereas [16] has a cost that is exponential in n (and linear in M). AdaFilter has much higher
power than simply applying multiplicity correction to M PC tests.
Deferring precise statements to later section, we give an intuitive explanation for how AdaFilter
gains power. Other things being equal, a larger M requires more stringent criteria on each p-
value under consideration in order to control some measure of simultaneous false discovery control.
Sometimes we know that a PC test for r−1 nonnull base hypotheses will not be rejected. We then
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know that the test for r nonnull hypotheses cannot be rejected either. As a result we can filter
the set of hypotheses to be tested down to a number m < M . This lowers the multiplicity burden,
increasing power. The more precise derivation to follow is based on the composite nature of a PC
test, reflected also in the fact that the rejection region in [0, 1]n has a complicated geometry.
We propose different versions of AdaFilter to target the control of simultaneous error rates as
FDR (false discovery rate) and FWER (familywise error rate). We rigorously prove FWER control
when all nM p-values are independent, and show with simulations that AdaFilter is robust to
within-study dependence and its more liberal version controls FDR.
AdaFilter’s power gain is linked to its ability to learn from the data which PC hypotheses are
likely to be null. This translates, perhaps surprisingly, in a lack of “monotonicity” of the number
rejections in the p-values. Lowering any p-value in a row of the p-value matrix can only raise the
chance that the corresponding test is rejected in the study corresponding to that row. However,
when looking across studies, lowering one p-value in the n×M matrix can make it harder for the
PC hypothesis relative to a different column to be rejected as it can reduce the ‘similarity’ among
the n studies. That is AdaFilter lacks ‘complete monotonicity’ with respect to the underlying
p-values.
There has been much other recent literature on efficient FDR control by using some special data
structure as prior knowledge [21, 22, 3, 7] and then adaptively determining the selection threshold.
AdaFilter shares some similar adaptive filtering ideas, but works directly from an n ×M matrix
of p-values without assuming any special structure and is uniquely tailored to the special nature
of the PC hypotheses.
Finally, we remark that the partial conjunction hypotheses are of interests in contexts other
then replicability, whenever scientists are interested in studying if a given “mechanism” operates
under multiple conditions. For example, in multiple tissue eQTL studies, PC can identify genes
with consistent regulation over tissues, one of the aims of [12] and [31]. In GWAS of multiple
phenotypes [26], PC can identify the single nucleotide polymorphisms (SNPs) that are associated
with more than one trait, and therefore are likely to probe an important biological pathway.
The structure of the paper is as follows. Section 2 precisely defines PC testing, and illustrates the
power limitation of direct multiplicity adjustment of PC p-values. Section 3 introduces our AdaFil-
ter procedures. Section 4 proves their validity under independence, provides further understanding
of the procedures from the monotonicity property and makes a comparison with previous meth-
ods. Section 5 explores the performance with simulations allowing for within-study dependence.
Section 6 applies AdaFilter to two case studies, one testing for replication in multiple experiments
and the other for signal consistency across different subgroups. Section 7 has conclusions. An R
package implementing AdaFilter is available at: https://github.com/jingshuw/adaFilter
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2 Multiple testing for partial conjunctions
2.1 Problem setup
We consider the problem where M null hypotheses are tested in n studies. The individual null
hypotheses are (H0ij)n×M . In high-throughput genetic experiments, M is the number of genes
or SNPs. In many applications, only summary statistics are available. We work with summary
statistics that are p-values (pij)n×M for (H0ij)n×M . Each pij is the realization of a random variable
Pij. A valid P -value for a null hypothesis H0 satisfies P(P ≤ γ) ≤ γ under H0. We assume that
each Pij is valid for H0ij. Also, let P(1)j ≤ P(2)j ≤ · · · ≤ P(n)j be the sorted P-values of each
j = 1, 2, . . . ,M .
Definition 1. (Partial Conjunction Hypothesis) For integers n ≥ r ≥ 2, the partial conjunction
(PC) null hypothesis is:
H
r/n
0 : fewer than r out of n base hypotheses are nonnull.
Definition 1 includes the case r = n which is a conjunction test. Our n base hypotheses in a
PC test will have statistically independent p-values. The p-values from those base tests will be
combined into a p-value for a PC test. For each SNP or gene j ∈ 1:M ≡ {1, 2, . . . ,M}, we test a
partial conjunction null hypothesis H
r/n
0j .
For a multiple testing procedure on {Hr/n01 , . . . , Hr/n0M }, denote the decision function as ϕj = 1
if we reject H
r/n
0j and ϕj = 0 otherwise. The total number of discoveries is then R =
∑M
j=1 ϕj. Of
these, the number of false discoveries is V =
∑M
j=1 ϕj1vj=0 where vj = 0 if the jth null is true and
vj = 1 otherwise.
There are many measures of the simultaneous error rate [10], with FWER and FDR being the
most common ones. In addition, we consider the per-family error rate (PFER), as it provides
a motivation for our procedures. With the notation introduced, the FWER:= P(V ≥ 1), the
PFER:= E(V ) and the FDR:= E(V/max(R, 1)).
2.2 Direct multiple comparison adjustment procedures on PC p-values
First, we briefly review p-value construction for a single PC hypothesis. More details can be
found in [30] and [5]. Consider a single PC null hypothesis H
r/n
0 with a vector of base P-values
(P1, P2, . . . , Pn) obtained from n studies and let Pr/n denote the P-value for H
r/n
0 obtained by
combining the individual P-values into a single one. [5] discuss three approaches, which we report
here, using the standard notation (P(1) ≤ P(2) ≤ · · · ≤ P(n)):
1. Simes’ method: P Sr/n = min r≤i≤n
{
n−r+1
i−r+1 P(i)
}
,
2. Fisher’s method: P Fr/n = P
(
χ2(2(n−r+1)) ≥ −2
∑n
i=r logP(i)), and
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3. Bonferroni’s method: PBr/n = (n− r + 1)P(r).
The idea is to apply meta-analysis to the largest n− r+ 1 individual P-values. Using any of these
rules on valid base p-values we obtain a valid PC p-value Pr/n,j for j = 1, . . . ,M .
One could simply apply standard multiplicity adjustment procedures to the individual PC P-
values {Pr/n,j : j = 1, . . . ,M}. For example, to control the FWER at level α, we could use the
Bonferroni rule, which rejects H
r/n
0j if Pr/n,j ≤ α/M . This would also control the PFER at level α
[29]. To control the FDR we could use the BH procedure [6], if the Pr/n,j are independent. We call
this the “direct approach” below.
This direct approach is often too conservative, as we show next for the case r = n. To quantify
how the performance of this procedure interplays with the composite nature of a PC null hypothesis,
define sets Ik ⊂ 1:M such that
Ik =
{
j ∈ 1:M | exactly k of H01j, . . . , H0nj are false
}
for k = 0, . . . , n. Assuming that the individual PC p-values for each SNP or gene j are independent,
then
FWER = E(V ) =
n−1∑
k=0
∑
j∈Ik
P(P(n)j ≤ α/M) ≤
n−1∑
k=0
∑
j∈Ik
αn−k
Mn−k
=
n−1∑
k=0
|Ik| α
n−k
Mn−k
. (1)
The inequality in (1) is close to an equality when all the tests of non-null hypotheses H1ij have
high power. When M is large, let δk = |Ik|/M . The above bound is approximately
E(V ) ≈ α
{
δn−1 + δn−2
α
M
+ δn−3
( α
M
)2
+ · · ·+ δ0
( α
M
)n}
and in the limit it is dominated by δn−1α (when δn−1 6= 0) or is of order O(M−1) (when δn−1 = 0).
Thus, when δn−1 ≈ 0, which is a typical scenario in genetics problems where the signal is very
sparse, the expected number of rejections E(V ) is much less than its nominal level α and the
procedure can become highly deficient, in fact much more conservative than Bonferroni usually is.
The point is that if we do not account for the fact that the PC null is composite, we will control
the global error rates under the worst case scenario (δn−1 = 1), which is unnecessary. For general
r ≤ n, the level of E(V ) for Bonferroni correction of individual PC p-values will depend mainly on
δr−1 in the large M setting. So does the BH control for FDR.
It is clear that there can be more efficient procedures if the fractions δk were known or if good
estimates of δk can be obtained. This is what motivates the Bayesian methods [16, 12]. In this
paper we take a frequentist perspective. Rather than estimating δk, AdaFilter works directly on
an alternative estimation of V and implicitly and adaptively adjusts for the size of δr−1, fraction
of the least favorable nulls.
3 The idea of AdaFilter
In the previous section, we showed that a PC null hypothesis is composite, thus the inequality
P(Pr/n ≤ γ) ≤ γ for a given γ can be very loose, while standard multiple testing procedures are
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designed to control error when P(Pr/n ≤ γ) = γ. To overcome this, AdaFilter leverages a region
Aγ ⊂ [0, 1]n such that the much tighter inequality P(Pr/n,j ≤ γ | (P1j, . . . , Pnj) ∈ Aγ) ≤ γ holds
for any configuration in the PC null space.
In Figure 1a, we use the case of n = r = 2 to illustrate the construction of a set Aγ. The PC test
j has base p-values P1j and P2j, and its PC p-value is P2/2,j = max(P1j, P2j). The null H
2/2
j0 contains
three configurations: (H01j, H02j) is (True,True), (True,False) or (False,True). It is easy to see
that P(P2/2,j ≤ γ) = γ2 under the first scenario, which can be much lower than γ. However, if we
condition on (P1j, P2j) being in the “L”-shaped filtering region Aγ = {(p1, p2) | min(p1, p2) ≤ γ},
we get P(P2/2,j ≤ γ | (P1j, P2j) ∈ Aγ) ≤ γ for all three null scenarios, which is a much tighter
inequality. The inequality holds since at least one of P1j and P2j is stochastically greater than
uniform under all three scenarios.
Since Bonferroni and BH procedures are based on an implicit estimate of the number of false
rejections V associated with a threshold γ: V̂γ = γM , we can improve their efficiency with a
smaller estimate of V̂γ using the new inequality. In other words, the estimated V is now V̂Aγ =
γ ×∑Mj=1 1(P1j ,P2j)∈Aγ . The quantity (1/M)∑Mj=1 1(P1j ,P2j)∈Aγ can be understood as an estimate
of the fraction δr−1 of the least favorable nulls. Hypotheses that fall outside of the “L”-shaped
filtering region are not counted towards the multiplicity of the PC hypotheses. If this quantity
is small, then more unlikely candidate hypotheses are filtered out and V̂Aγ provides a much lower
estimate than V̂γ.
To control the FWER (and PFER) at level α, we adaptively choose γ as large as possible,
subject to V̂Aγ ≤ α. Similarly, to control the FDR at level α, we estimate the false discovery
proportion V/R as V̂Aγ/R and select the largest γ ≥ 0 such that V̂Aγ/max(R, 1) ≤ α. Figure 1b
illustrates how the estimates V̂Aγ and V̂Aγ/max(R, 1) change as functions of γ under the complete
null scenario (when all H
2/2
j0 are true).
3.1 AdaFilter procedures for partial conjunctions
Now we formally define AdaFilter for general n and r. It is convenient to first introduce the notion
of filtering and selection P -values. These are
Fj := (n− r + 1)P(r−1)j, and (2)
Sj := P
B
r/n,j = (n− r + 1)P(r)j, (3)
respectively. The filtering region is defined as:
Aγ :=
{
(p1, p2, . . . , pn) | (n− r + 1)p(r−1) ≤ γ
}
.
Definition 2 (AdaFilter Bonferroni). For a level α, and with Fj and Sj given by (5) and (6)
respectively, reject H
r/n
0j if Sj ≤ γBon0 where
γBon0 = max
{
γ ∈ { α
M
, . . . ,
α
2
, α
} ∣∣∣ γ M∑
j=1
1Fj≤γ ≤ α
}
.
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Definition 3 (AdaFilter BH). For a level α, and with Fj and Sj given by (5) and (6) respectively,
reject H
r/n
0j if Sj ≤ γBH0 where
γBH0 = max
{
γ ∈ Iα,M
∣∣∣ γ M∑
j=1
1Fj≤γ ≤ α
M∑
j=1
1Sj≤γ
}
, and
Iα,M =
{ k
m
α
∣∣ k ∈ {0, 1, . . . ,M}, m ∈ {1, . . . ,M}, k ≤ m}.
Our AdaFilter Bonferroni can be defined equivalently using a more programmable two-step
approach for the convenience of computation. For details, see Web Appendix A.
AdaFilter removes unlikely candidates based on Fj and then adjusts for the multiplicity of the
remaining hypotheses. Lemma 4.2 in the next section, provides a ‘conditional validity’ of Fj and
Sj, that removes the need to correct for any potential selection bias.
4 Theoretical properties of AdaFilter
When the P-values are independent across both the studies and the multiple individual hypotheses,
we can prove that the AdaFilter Bonferroni controls PFER (and FWER) under any configurations
of the true individual hypotheses.
Theorem 4.1. Let (Pij)n×M contain independent valid p-values. Then the AdaFilter Bonferroni
procedure in Definition 2 controls FWER and PFER at level α for the null hypotheses {Hr/n0j : j =
1, 2, . . . ,M}.
The proof of Theorem 4.1 is in Web Appendix B. It relies on the following ‘conditional validity’
property of Sj after filtering via Fj also proved in Web Appendix B.
Lemma 4.2. (Conditional validity) Let (Pij)n×M contain independent valid p-values. When
H
r/n
0j is true, then for any β > 0
P
(
Sj ≤ β | Fj ≤ β
) ≤ β (4)
holds whenever P
(
Fj ≤ β
)
> 0. Here Fj and Sj are given by (5) and (6) respectively.
Inequality (4) can be equivalently written as P
(
Sj ≤ β
) ≤ βP(Fj ≤ β). This also holds when
P(Fj ≤ β) = 0 as Sj ≥ Fj is always true.
The independence of the tests for the hypotheses within a study is a common assumption. For
instance, the BH procedure [6] was developed for and works best on independent p-values. Still,
for many problems, independence is unrealistic. Fortunately, our simulations in Section 5 show
that AdaFilter is robust to violations of the hypothesis of independence between tests in a study.
In addition, they illustrate how AdaFilter BH appears to guarantee FDR control.
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4.1 Lack of complete monotonicity
The increased power of AdaFilter can lead to a striking efficiency. Suppose that we have n studies,
each testing the involvement of M genes in a disease. One researcher uses a multiple testing
adjustment—such as BH or Bonferroni—separately on the M p-values of each of the n studies. He
claims that a gene is important for the pathology as long as the null hypothesis relative to this gene
is rejected in at least one of them. Another researcher runs AdaFilter on the same data: she claims
that a gene is important only when, accounting for the multiplicity across genes, she can reject the
null hypotheses that the gene is significant in less than two studies. The second researcher has a
stricter goal and yet it is possible that she makes more discoveries than the first.
To see how this could happen, consider the toy example in Figure 1c where M = 2. In both
studies, none of the two hypotheses can be rejected at significance level α = 0.05 when using
multiple testing corrections (either Bonferroni or BH) on each study separately. However, both
AdaFilter Bonferroni and AdaFilter BH reject H
2/2
0 at level 0.05 for the first hypothesis.
This striking phenomenon arises from the lack of monotonicity we mentioned in the introduc-
tion. A multiple hypothesis testing method has “complete monotonicity” if reducing any of the
underlying p-values can never cause any of the decisions on the null hypotheses to switch from
‘reject’ to ‘accept’. Simes’, Fisher’s and Bonferroni’s meta-analyses have complete monotonicity.
So does the BH procedure. [14] call this property “stability”. It holds for the PC tests of [15].
The different versions of AdaFilter work with a matrix of p-values. They have a “partial mono-
tonicity” property whereby reducing one of the n p-values for test j can never change the decision
from reject H
r/n
0,j to accept (for more details, see Web Appendix A). However, they do not satisfy
complete monotonicity: lowering one of the p-values for gene j can change the rejection of H
r/n
0,j′ to
acceptance for j′ 6= j.
Figure 1d shows how AdaFilter does not have complete monotonicity. Compared with Figure 1c,
the second hypothesis has a decreased p-value in study 1 while all other p-values are kept fixed. In
Figure 1c, both γBon0 = γ
BH
0 = 0.05 so the first PC hypothesis is rejected. In contrast, in Figure 1d
γBon0 = 0.025 and γ
BH
0 = 0 so that none of the hypotheses can be rejected though it has a smaller
p-value matrix.
This lack of complete monotonicity, which might appear undesirable, in fact is at the core
of the efficiency of AdaFilter. A larger Pij can increase Fj causing gene j to be removed from
the comparison. This reduces the multiplicity burden, allowing the selection statistic Sj′ to be
less stringent. When only a few hypotheses are non-null—as in a sparse genomics setting—we
expect lots of large Pij. This gives AdaFilter a substantial advantage in identifying the few nonnull
PC hypotheses. From another perspective, an increased individual p-values can make the signal
configuration across genes more similar among studies (such as Figure 1c compared to Figure 1d).
AdaFilter can implicitly learn such similarity and utilize it to allow more rejections.
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4.2 Extensions and relation to literature
Remark 1: variable r and n In many genetic problems, the M genes or SNPs can have
varying rj or nj as they may not be present in every single experiment. Then the jth PC null
hypothesis is simply H
rj/nj
0j . AdaFilter procedures still work in this scenario. We only need to
replace formulas (5) and (6) by Fj = (nj − rj + 1)P(rj−1)j and Sj = (nj − rj + 1)P(rj)j respectively.
AdaFilter is still valid because the conditional validity Lemma 4.2 still holds.
Remark 2: comparison with other strategies Two related methods are [8] for replicability
analysis where n = r = 2 and the empirical Bayes approach in [16] for controlling the Bayes
FDR for multiple PC tests. Both methods were developed to improve the efficiency of the direct
approach we described. AdaFilter is similar to the method of [8] but works for arbitrary n and r.
It provides a frequentist approach comparable to and sometimes better than [16].
The procedures of [8] use a filtering step for each study based on the p-values in the other study
and a selection step that rejects hypotheses that have small enough p-values in both studies. To
maximize the efficiency, the authors suggest a data-adaptive threshold. For instance, to control
FWER, they chose two thresholds γ1 and γ2 to satisfy γ1
(∑M
j=1 1P2j≤γ2
) ≈ α/2, and γ2(∑Mj=1 1P1j≤γ1) ≈
α/2. When γ1 ≈ γ2, then
γ1
( M∑
j=1
1min(P1j ,P2j)≤γ1
) ≤ γ1{ M∑
j=1
(
1P1j≤γ1 + 1P2j≤γ1)
} ≈ α.
Thus γBon0 ≈ γ1 ≈ γ2 and AdaFilter becomes similar to theirs. The proposed method only applies
for n = r = 2; this simplification makes the approach less widely applicable, despite its strong
theoretical guarantees.
[16] tried to learn the proportion of each of the 2n possible configurations of individual hypothe-
ses being null or non-null, along with the distribution of some Z-values under each configuration.
This has cost at least O(M2n). AdaFilter has cost O(Mn log(n)) and in our simulations below it
is more powerful because it is not overly conservative.
Remark 3: testing for all possible values of r The partial conjunction null H
r/n
0 can be
meaningfully defined for any 2 ≤ r ≤ n, and sometimes it is of interest to test for all possible r
values, adding another layer of multiplicity. As the filtering information learnt by AdaFilter varies
for different r values, a signal that is rejected by a larger r using AdaFilter is not guaranteed to
also be rejected at a smaller replicability level. The current formulation of AdaFilter is therefore
not suited to data dependent selection of the r value, but requires this to be specified by the user.
5 Simulations
We benchmark the performance of AdaFilter versus direct multiple comparison correction proce-
dures on the three forms of PC p-values in Section 2.2. For FDR control, we also include the
empirical Bayes method in [16], using their R package repfdr. We allow for dependence across the
individual hypotheses within each study and include both weak and strong dependence scenarios.
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We set M = 10,000. We consider six different configurations of n and r, as listed in Table 1a.
For a given n, there are 2n combinations of individual hypotheses being null or non-null. In
generating different configurations of the truth, we use two parameters to control the probability
of each combination: pi0 is the probability of the global null combination and pir/n is the probability
of the combinations not belonging to H
r/n
0j . We set pir/n = 0.01 and consider two values for pi0: 0.8
or 0.98, to mimic the signal sparsity in gene expression and genetic regulation studies. All PC null
combinations except for the global null have equal probabilities adding up to 1 − pi0 − pir/n. All
non-null PC combinations also have equal probabilities.
We assume that p-values belonging to different studies are independent and, within one study,
the correlation of the M Z-values is Σρ ⊗ Ib×b where ⊗ is the Kronecker product. The covariance
Σρ ∈ Rm×m has 1s on the diagonal and common value ρ = 0.5 off the diagonal. We set the block
size b = 100 for weak dependence structure and b = 1000 for strong dependence. We believe that
these levels of dependence cover the spectrum of what is typically expected in genomics. (Note
that we calculate two-sided p-value so that the actual dependence among the p-values is not going
to be only positive.) When the individual component hypothesis is non-null, we sample the mean
of the z-value uniformly and independently from I = {±µ1,±µ2,±µ3,±µ4} where the four levels
of signals {µ1, µ2, µ3, µ4} correspond to detection power of 0.02, 0.2, 0.5, 0.95 respectively.
In the analysis, we target control of PFER at the nominal level α = 1, FDR at the nominal
level α = 0.2, and Bayes FDR at the same level α = 0.2 for repfdr. Bayes FDR corresponds to
the posterior probability that an hypothesis whose test statistics falls in the rejection region is null,
which has been shown to be similar to the frequentist FDR under independence [11]. Studying
PFER control, we compare AdaFilter Bonferroni procedure with direct application of the Bonfer-
roni correction to the three forms of the PC p-values in Section 2.2. We analyze five procedures
controlling FDR: AdaFilter BH, repfdr and the three procedures with direct BH correction. For
each parameter configuration, we run B = 100 random experiments and calculate the average
power, number of false discoveries and false discovery proportions of each procedure.
All methods that target PFER (Table 1b, Web Figures 1-2) successfully control it at the
nominal level, while the direct methods are much more conservative, especially when both n and
r are large. The gain in power is more pronounced when pi0 is higher, which is expected in many
genetics applications.
AdaFilter BH and the three direct correction procedures control FDR at the nominal level
(Table 1c, Web Figure 3-4). However, similar to what happens in the PFER control, the direct ap-
proaches are too conservative. The repfdr method fails to consistently control FDR at its nominal
level especially when n is large: we believe that this is due to the large number of parameters that
need to be estimated in these scenarios. In the cases when repfdr does control FDR, its power
is less than AdaFilter when pi0 is large and further reduces when dependence increases, indicating
that AdaFilter BH can be more powerful when applied to GWAS.
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Table 1: Simulation results
(a) Configurations of n and r
n 2 4 8 4 8 8
r 2 2 2 4 4 8
(b) Comparison of methods targeting a nominal PFER of α = 1
pi0 = 0.8 pi0 = 0.98
b = 100 b = 1000 b = 100 b = 1000
Method PFER Recall(%) PFER Recall(%) PFER Recall(%) PFER Recall(%)
Bonferroni-PBr/n 0.04 14.72 0.05 14.87 0.00 14.72 0.00 14.83
Bonferroni-P Fr/n 0.05 19.30 0.06 19.50 0.01 19.18 0.00 19.38
Bonferroni-P Sr/n 0.04 14.80 0.05 14.93 0.00 14.78 0.00 14.88
AdaFilter Bonferroni 0.73 28.71 0.76 28.93 0.29 38.10 0.21 38.25
(c) Comparison of methods targeting a nominal FDR of α = 0.2
pi0 = 0.8 pi0 = 0.98
b = 100 b = 1000 b = 100 b = 1000
Method FDR Recall(%) FDR Recall(%) FDR Recall(%) FDR Recall(%)
BH-PBr/n 0.01 29.53 0.01 29.59 0.00 29.40 0.00 29.34
BH-P Fr/n 0.02 33.00 0.02 33.04 0.00 32.77 0.00 32.65
BH-P Sr/n 0.01 29.71 0.01 29.72 0.00 29.55 0.00 29.49
repfdr 0.32 59.30 0.28 22.10 0.14 23.76 0.09 8.21
AdaFilter BH 0.15 58.27 0.15 58.75 0.06 71.13 0.06 70.97
6 Case studies
We use AdaFilter to analyze two datasets: one investigates the replication of gene differential
expression results in four experiments, while the other focuses on the discovery of signals that are
consistently significant across different metabolic super-pathways within one study.
6.1 Duchenne Muscular Dystrophy microarray studies
Following [19], we investigate four independent NCBI GEO Duchenne muscular dystrophy (DMD)-
related microarray datasets (GDS 214, GDS 563, GDS 1956 and GDS 3027, Table 2a).
For each experiment, the data is preprocessed using RMA [18] and the individual p-values for
each probe set are calculated using Limma [27] and then rescaled to achieve an approximately
uniform empirical null distribution (Web Figure 5).
The application of our AdaFilter BH procedure at level α = 0.05 leads to the discovery of many
consistently differentially expressed genes at r = 2, 3, 4 (Table 2b). Specifically, at r = 4, AdaFilter
BH finds 32 significant genes (Web Table 1). By contrast, a BH adjustment on the Fisher combined
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Table 2: Replicability analysis for DMD microarrays
(a) GEO datasets information
GEO ID Platform Description Source
GDS 214 custom Affymetrix 4 healthy, 26 DMD Muscle
GDS 563 Affymmetrix U95A 11 healthy, 12 DMD Quadriceps Muscle
GDS 1956 Affymetrix U133A 18 healthy, 10 DMD Muscle
GDS 3027 Affymetrix U133A 14 healthy, 23 DMD Quadriceps Muscle
(b) AdaFilter BH rejections
r M
Kept after
Rejected
filtering
2 13912 558 494
3 9848 330 142
4 1871 198 32
(c) Known marker genes detected by AdaFilter at r = 4
Gene Symbol GDS 214 GDS 563 GDS 1956 GDS 3027
MYH3 5.47e-14 2.18e-69 3.31e-07 2.49e-20
MYH8 5.74e-06 9.09e-11 2.58e-03 5.16e-33
MYL5 8.97e-04 3.06e-06 1.87e-03 6.63e-08
MYL4 1.48e-06 7.94e-08 1.21e-02 2.66e-08
PC p-values (P Fr/n,j) only detects two genes (MYH3 and S100A4) and repfdr reports no significant
genes as it fails to perform the distribution estimation of p-values as M = 1871 is not large enough
for r = 4. Table 2c shows four of the 32 genes that are known to be true positives as they all
play important roles in muscle contraction (Web Table 1). Notice that besides MYH3, all three
marker genes do not have a small enough p-value in the third study (GDS1956, which is the least
powerful study) to be detected separately. However, AdaFilter can compensate this deficiency by
leveraging the overall similarity of the results in this study compared with other studies. Finally,
besides these genes, many other significant genes also have related functions to muscle functions
and development, which are promising drug targets for the DMD disease (Web Table 1).
6.2 Metabolites super-pathways GWAS data
The multi-trait GWAS data from [26] is a comprehensive study of the genetic loci influencing human
metabolism: in addition to DNA variation, it measured the levels of 333 metabolites, categorized
into 8 non-overlapping “super pathways” (for more details, see Web Appendix A), and integrated
this data with gene expression and other prior information. [26] strongly emphasize how distinct
metabolic traits are linked through the effects of specific genes and indicates that the discovery
of genes that affect a diverse class of metabolic measurements is particularly interesting as these
genes are associated with complex trait/disease or drug responses.
Testing for partial conjunction is a means to discover such genes. Specifically, we apply AdaFil-
ter to the tests for association between SNPs and “super-pathways” (each SNP is linked to a gene,
and hence discovering a SNP points to a specific gene; super-pathways are defined in [26]).We
calculate the individual p-value for each SNP and each super-pathway by combining p-values of in-
dividual metabolic traits, giving appropriate consideration of the correlation of traits within each
super-pathway (see details in Web Appendix A). A simple estimation of the sample correlation
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matrix across all traits suggests that correlation between different super pathways is not large and
could be safely ignored (Web Figure 1).
Figure 2a compares the number of significant SNPs when FDR is controlled at 0.05 and r ranges
from 2 to 5. Compared with other four methods, our AdaFilter BH is much more powerful for any
value of r. The method repfdr rejects less than AdaFilter BH, which is a consistent result with
the simulations that repfdr may suffer from a power deficiency under dependence structures.
Among the significant SNPs at r = 3, 14 different SNPs are detected after clumping using
PLINK 1.9 ([24], Web Table 2), representing 13 different genes (Figure 2b). Many of these genes
have important roles in complex disease. For instance, gene GCKR encodes a regulatory protein
that inhibits glucokinase, which regulates carbohydrate metabolism, converting glucose to amino
acid and fatty acids. It is also a potential drug target for diabetes. Several genes (SLC17A3,
SLC2A9, SLC22A4, SLCO1B1) encoding the solute carrier (SLC) group of membrane transport
proteins are also detected. This suggests that they might function to transport multiple solutes
and could possibly be drug targets for diabetes, chronic kidney disease and various autoimmune
diseases.
7 Conclusion
Testing PC hypotheses provides a framework to detect consistently significant signals across multi-
ple studies, leading to an explicit assessment of the replicability of scientific findings. We introduced
AdaFilter, a multiple testing procedure which greatly increases the power in simultaneous testing
of PC hypotheses over direct methods. AdaFilter implicitly learns and utilizes the overall similarity
of results across studies and exhibits a lack of complete-monotonicity. We proved that AdaFilter
Bonferroni controls FWER under independence of all p-values. In our simulations AdaFilter is
robust to correlations among data from the same study, retaining control of FWER and FDR. The
validity of AdaFilter does require independence of the results between studies.
We applied AdaFilter to two case studies, encompassing gene expression and genetic associ-
ation. Other types of applications include eQTL studies and multi-ethnic GWAS (such as new
Population Architecture using Genomics and Epidemiology (PAGE) study) where it is of great
interest to understand which genetic regulations are shared and which are tissue / population spe-
cific. Actually, PC tests can be quite useful in even broader context. According to Hume [17],
“constant conjunction” is a characteristic of causal effects.
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S1 Web Appendix A: supplementary text
Here we provide a few details that are briefly discussed in the main text. Recall that we consider
the problem where M null hypotheses are tested in n studies (H0ij)n×M .The summary statistics are
the p-values (pij)n×M of the hypotheses in each of the studies, which is the realization of a random
matrix (Pij)n×M . We say that an error rate is controlled at level α when for any configuration of
true and non-true null hypotheses the expectations defining the error rates are bounded by α. We
use an upper case letter to denote a random variable and the corresponding lower case letter for
the specific realization of the random variable. Besides the notations in the main text, we define
p·j = (p1j, . . . , pnj) be the vector of p-values for individual hypotheses (H01j, . . . , H0nj) involved in
H
r/n
0j for each j = 1, 2, . . . ,M . Also, we use 1:M as a concise notation of the index set {1, 2, . . . ,M}.
S1.1 Alternative form AdaFilter Bonferroni
In the main text, we defined selection and filtering p-values:
Filtering P -values Fj :
Fj := (n− r + 1)P(r−1)j (5)
Selection P -values Sj
Sj := P
B
r/n,j = (n− r + 1)P(r)j (6)
and used them to define two procedures: AdaFilter Bonferroni and AdaFilter BH. For AdaFilter
Bonferroni, there exists an equivalent but more programmable two-step alternative approach.
Definition 4 (AdaFilter Bonferroni, alternative version). For a level α > 0, and with Fj
and Sj given by (5) and (6) respectively, proceed as follows. First sort {F1, F2, · · · , FM} into
F(1) ≤ F(2) · · · ≤ F(M). Then let
m′ = min
{
j ∈ 1:M ∣∣ α
j
< F(j)
}
(7)
and define
m =
{
m′, if F(m′) ≤ αm′−1
m′ − 1, otherwise.
Finally, reject H
r/n
0j if Sj ≤ α/m. If the set in (7) is ∅, then take m′ = m = M .
This alternative version is also demonstrated in Web Figure 7. Pairs of (Fj, Sj) are ordered
into (F(j), Sj?) (where j
? is determined via Fj? = F(j)) by the value of Fj. Then, by comparing
the curve of α/j, j = 1, · · · ,M , a filtering threshold m is determined and only the m pairs with
smallest Fj values are kept. Finally, hypothesis H
r/n
0j is rejected if Sj ≤ α/m.
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Proposition S1.1. The two definitions of the Adaptive filtering Bonferroni procedure are equiva-
lent.
This proposition is proved in Section S2.3 of this supplement. The alternative form provides
another view of the AdaFilter procedures. We filter out unlikely hypotheses with large Fj values
and only adjust for the m remaining hypotheses. If m  M then adaptive filtering can reject
many more hypotheses than direct Bonferroni or BH on Sj.
S1.2 Partial monotonicity
In the main text, we discussed that AdaFilter does not satisfy “complete monotonicity”, which is
crucial for its efficiency. However, it does satisfy “partial monotonicity”, making it an intuitively
reasonable procedure.
Definition 5 (Partial monotonicity). A multiple testing procedure has partial monotonicity if for
all j ∈ 1:M , its decision function ϕj(p·1, · · · , p·M) is non-increasing in all elements of (p1j, p2j, . . . , pnj).
Partial monotonicity only requires the test of hypothesis j to be monotone in the p-values for
that same hypothesis. It allows a reduction in pij′ for j
′ 6= j to reverse a rejection of Hr/n0j . We
have the following result:
Corollary S1.2. Let (Pij) be a matrix of valid p-values. Then both the AdaFilter Bonferroni
and the AdaFilter BH procedures satisfy partial monotonicity for all null hypotheses H
r/n
0j , j =
1, 2, · · · ,M .
S1.3 More details for the analysis of metabolites super-pathways GWAS
data
In [26], A total of 7824 adult individuals from 2 European populations were recruited in the study,
and M = 2,182,555 SNPs were recorded, either directly genotyped or imputed from the HapMap
2 panel. Out of the 333 annotated metabolite traits reported in the paper, only 275 have the
summary statistics (t statistics and p-values for the association of each SNP and trait) publicly
available at the Metabolomics GWAS Server http://mips.helmholtz-muenchen.de/proj/GWAS/
gwas/index.php?task=download, which is the data we use for analysis.
To calculate individual p-values pij for each marker j and each super-pathway i, we start with
the Z-values Zsj for test of association between each metabolite s and marker j, which are given
as summary statistics. For a super-pathway i, let {s1, s2, · · · , sni} be the index set of metabolite
measures that belong to it. We assume that (Zs1j, Zs2j, · · · , Zsnij) ∼ N (0,Σi). The covariance Σi
can be accurately estimated in principle since we have millions of markers. Most of the individual
hypotheses are null and the noise of the estimates of the marginal effects of these SNPs should
share a common correlation matrix [9]. We estimate Σi using graphical Lasso, assuming that the
precision matrix is sparse. To do this, we randomly sample 2000 SNPs (markers) that lie at least
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1Mbp away from each other, so that they can be considered as independent SNPs. Then these
SNPs are treated as samples in Graphical Lasso and the tuning parameters of the final estimates
selected by cross-validation. The Graphical Lasso approach guarantees an accurate sparse inverse
covariance matrix estimation, that is needed for computing the p-values for each super-pathway.
Let pij be the p-value for the association between a super-pathway i and marker j, in other
words, the p-value for the null
Hij0 : no metabolite measure of super pathway i is associated with marker j.
Given (Zs1j, Zs2j, · · · , Zsnij) and Σˆi, we calculate p-values pij from the chi-square test treating the
estimated Σi as known. These pij serve as individual p-values which will be used in the partial
conjunction testing. Web Figure 6 shows the estimated correlation across metabolites assuming
(Z1j, Z2j, · · · , Zmj) ∼ N (0,Σ) for j = 1, 2, · · · ,M . We estimate Σ by applying the Minimum
Covariance Determinant (MCD) [25] estimator to the 2000 randomly sampled SNPs, where MCD
is a highly robust method to reduce the influence of the sparse non-null hypotheses. Notice that we
choose MCD instead of graphical Lasso here as we do not need an estimate of the inverse of Σ. It is
evident that most of the nonzero correlations are between traits within the same super-pathways:
this allows us to apply the adaptive filtering procedures for PC hypotheses across super-pathways
with confidence.
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S2 Web Appendix B
Here we provide proofs for all the theoretical results in Section 3 and Section 4 of the main text,
and Web Appendix A.
S2.1 Proof of Lemma 1
We use u ⊆ {1, 2, · · · , n} to represent a subset of the studies. This set u has cardinality |u|. We
use −u to denote its complement {1, 2, · · · , n}\u.
Choose β > 0 and let β˜ = β/(n− r + 1). By independence of Pij,
P(P(r)j ≤ β˜) =
n∑
k=r
∑
|u|=k
∏
i∈u
P(Pij ≤ β˜)
∏
i∈−u
P(Pij > β˜), and
P(P(r−1)j ≤ β˜) =
n∑
k=r−1
∑
|u|=k
∏
i∈u
P(Pij ≤ β˜)
∏
i∈−u
P(Pij > β˜).
Next, because H
r/n
0j is true, for any u ⊂ 1:n with |u| ≥ r there is at least one index i∗ =
i∗(u, j) ∈ u for which H0i∗j is true. Because all the Pij are valid,
P(Sj ≤ β) = P(P(r)j ≤ β˜)
=
n∑
k=r
∑
|u|=k
(∏
i∈u
P(Pij ≤ β˜)
∏
i∈−u
P(Pij > β˜)
)
≤ β˜ ·
n∑
k=r
∑
|u|=k
( ∏
i∈u\{i∗}
P(Pij ≤ β˜)
∏
i∈−u
P(Pij > β˜)
)
= β˜ ·
n∑
k=r
∑
|u|=k
( ∏
i∈u\{i∗}
P(Pij ≤ β˜)
∏
i∈−u
P(Pij > β˜)
[
P(Pi∗j ≤ β˜) + P(Pi∗j > β˜)
])
= β˜ ·
n∑
k=r
∑
|u|=k
(∏
i∈u
P(Pij ≤ β˜)
∏
i∈−u
P(Pij > β˜)
)
+ β˜ ·
n∑
k=r
∑
|u|=k
( ∏
i∈u\{i∗}
P(Pij ≤ β˜)
∏
i∈−u∪{i∗}
P(Pij > β˜)
)
≤ β˜ ·
n∑
k=r
∑
|u|=k
(∏
i∈u
P(Pij ≤ β˜)
∏
i∈−u
P(Pij > β˜)
)
+ β˜ ·
n−1∑
k=r−1
(n− k)
∑
|u|=k
(∏
i∈u
P(Pij ≤ β˜)
∏
i∈−u
P(Pij > β˜)
)
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≤ (n− r + 1)β˜ · P(P(r−1)j ≤ β˜).
Thus
P
(
Sj ≤ β | Fj ≤ β
)
=
P(P(r)j ≤ β˜)
P(P(r−1)j ≤ β˜)
≤ β.
S2.2 Proof of Theorem 1
For j = 1, 2, · · · ,M , define
γj = max
{
γ ∈ {α, α
2
, · · · , α
M
}
: γ · (1 +
∑
s 6=j
1Fs≤γ) ≤ α
}
.
It is obvious that if Fj ≤ γBon0 , then γj = γBon0 , otherwise γj ≤ γBon0 . Then the PFER is,
E(V ) = E
( M∑
j=1
1Sj≤γBon0 · 1vj=0
)
= E
( M∑
j=1
1Sj≤γBon0 1Fj≤γBon0 · 1vj=0
)
=
M∑
j=1
E
(
1Sj≤γj · 1Fj≤γBon0 · 1vj=0
)
=
M∑
j=1
E
(
1Sj≤γj · 1Fj≤γj
)
· 1vj=0
Recall that γj does not depend on P·j while (Fj, Sj) only depends on P·j. Therefore γj is
independent of (Fj, Sj) by our assumption on (Pij). Now using the conditional validity in Lemma 1
of the main article,
E(V ) = E
(
M∑
j=1
E
[
1Sj≤γj | γj, 1Fj≤γj
]
· 1Fj≤γj · 1vj=0
)
≤ E
( M∑
j=1
γj · 1Fj≤γj · 1vj=0
)
≤ E
(
γBon0 ·
M∑
j=1
1Fj≤γBon0 · 1vj=0
)
≤ α.
S2.3 Proof of Proposition S1.1
To show that the two definitions are equivalent, we only need to show that m = γBon0 always holds.
Define
S =
{
γ ∈ [0, 1] : γ ·
M∑
j=1
1Fj≤γ ≤ α
}
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First consider the case when the set in (7) is not ∅. As F(m′) > α/m′, it can be shown that for
any γ ≥ F(m′) we have γ /∈ S. This is because both γ > α/m′ and
∑M
j=1 1Fj≤γ ≥ m′. Also, as
F(m′−1) ≤ α/(m′− 1), it can be shown that for any γ > α/(m′− 1) we have γ /∈ S. This is because
both γ > α/(m′ − 1) and ∑Mj=1 1Fj≤γ ≥ m′ − 1.
As a consequence, when F(m′) > α/(m
′−1), it can be easily checked that α/(m′−1) ∈ S. Thus,
γBon0 = α/(m
′ − 1) = α/m. On the other hand, when F(m′) ≤ α/(m′ − 1), we have α/(m′ − 1) /∈ S
while α/m′ ∈ S. Thus, γBon0 = α/m′ = α/m.
Finally, when the set in (7) is ∅, it means that α/M ≥ F(M). In this scenario, γBon0 = α/M =
α/m as we set m = M in Definition S1.
S2.4 Proof of Corollary S1.2
For some j, let p˜·j = (p˜1j, · · · , p˜nj) satisfy p˜ij ≤ pij for i = 1, 2, · · · , n. Now construct a new
N × n P -value matrix P˜ with the given row P˜·j and all other rows P˜·k = P·k for k 6= j. Define
(F˜1, · · · , F˜M) as the corresponding filtering statistics (5) and (S˜1, · · · , S˜M) as the corresponding
selection statistics (6) with P˜ replacing P . Then F˜k = Fk and S˜k = Sk for k 6= j and F˜j ≤ Fj with
S˜j ≤ Sj.
For the AdaFilter Bonferroni procedure, let γ˜Bonj be the new γ
Bon
0 using the new individual
P-values. For the AdaFilter BH procedure, let γ˜BHj be the new γ
BH
0 using the new individual p-
values. Then to show that the procedures satisfy partial monotonicity, we only need to show that
if Sj ≤ γ0, then S˜j ≤ γ˜j for both the Bonferroni correction and BH.
For the AdaFilter Bonferroni procedure, if Sj ≤ γ0, then S˜j ≤ γ0, thus
γBon0 ·
M∑
k=1
1F˜k≤γBon0 ≤ α
which means that γ˜Bonj ≥ γBon0 . Similarly, for the AdaFilter BH procedure using the same argument,
we have γ˜BHj ≥ γBH0 when Sj ≤ γ0. As a consequence, for both AdaFilter procedures, we have
S˜j ≤ Sj ≤ γ0 ≤ γ˜j.
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Figure 1: Illustration of the AdaFilter idea. (a) For n = r = 2, rejection (red) and filtering (L-
shaped blue) regions at γ = 0.3 are shown. Each triangle corresponds to a pair of p-values. (b)For
n = r = 2, AdaFilter estimated V and FDP selection of γ is shown as a function of γ under the
complete null scenario. The cross is the selected value of γ when the error rates are controlled at
α = 0.1. The red dashed lines are the lines at α = 0.1 (c) Toy example showing that AdaFilter is
more efficient than testing for each study separately. Values are the p-values. (d) Compare with
(c) as a counterexample to show that AdaFilter violates “complete monotonicity”.
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Figure 2: (a) Metabolics GWAS data: the number of SNPs whose Hr/n null hypotheses were
rejected by each of the compared procedures. FDR is controlled at α = 0.05. (b) Visualization
of individual p-values of the super-pathways for the 13 clumped significant SNPs (their mapped
genes are labeled) detected at r = 3 (Web Table 2). For the two SNPs that map to the same gene,
only the more significant one is shown. The significant p-values have a blue color. The darker the
color, the smaller the p-value is.
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P4/4 GO Biological Process
MYH3 3.31e-07 actin filament-based movement, muscle organ development,
striated muscle contraction
S100A4 1.11e-06 epithelial to mesenchymal transition
S100A10 1.50e-04 signal transduction, regulation of cell growth, regulation of cell differentiation
S100A13 2.87e-04 cell differentiation
TMSB10 7.45e-04 sequestering of actin monomers, actin cytoskeleton organization
PLAU 1.15e-03 angiogenesis, fibrinolysis, signal transduction, regulation of cell proliferation,
blood coagulation, smooth muscle cell migration, embryo implantation,
skeletal muscle regeneration, chemotaxis <more data available...>
CLIC1 1.33e-03 signal transduction, transport, ion transport, chloride transport,
response to unfolded protein, response to nutrient, defense response
PLA2G2A 1.64e-03 negative regulation of cell proliferation, somatic stem cell maintenance, negative
regulation of epithelial cell proliferation, positive regulation of foam cell
differentiation, positive regulation of inflammatory response
<more data available...>
MYL5 1.87e-03 regulation of muscle contraction
CHRNA1 2.11e-03 signal transduction, muscle maintenance, neuron maintenance, regulation of
membrane potential, regulation of action potential in neuron, neuromuscular
synaptic transmission, neuromuscular junction development, skeletal muscle tissue
growth, transport, ion transport <more data available...>
TYROBP 2.31e-03 intracellular signaling cascade, cellular defense response
ART3 2.46e-03 protein amino acid ADP-ribosylation
MYH8 2.58e-03 biological process, striated muscle contraction
DAB2 3.37e-03 negative regulation of cell growth, cell proliferation, cell morphogenesis involved in
differentiation, pinocytosis, receptor-mediated endocytosis, in utero embryonic
development, excretion
S100A11 3.71e-03 negative regulation of cell proliferation, negative regulation of DNA replication,
signal transduction
LAPTM5 4.48e-03 transport
EEF1A1 4.59e-03 translational elongation
IGFBP4 4.82e-03 signal transduction, regulation of cell growth, intracellular signaling cascade,
cell proliferation, DNA metabolic process, skeletal system development,
inflammatory response
TUBA1A 7.97e-03 protein polymerization, microtubule-based process, microtubule-based movement
F13A1 8.43e-03 blood coagulation, peptide cross-linking, wound healing
RPL3 9.97e-03 biological process, translation, translational elongation
ANXA2 1.10e-02 angiogenesis, fibrinolysis, collagen fibril organization
PPP1R1A 1.20e-02 signal transduction, glycogen metabolic process, carbohydrate metabolic process
MYL4 1.21e-02 regulation of the force of heart contraction, positive regulation of ATPase activity,
muscle organ development, cardiac muscle contraction
SRPX 1.28e-02 biological process, cell adhesion
HLA-DPB1 1.44e-02 immune response, antigen processing and presentation of peptide or
polysaccharide antigen via MHC class II
Table S1: 27 or the 32 AdaFilter selected genes for r = 4 with FDR controlled at α = 0.05 where
functional annotations are available in [19](Table S2). The AdaFilter selection p-values for theses
genes are also reported.
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Gene Amino acid Carbohydrate Cofactors Energy Lipid Nucleotide Peptide Xenobiotics
and vitamins
rs780093 GCKR 1.1e-25 7.4e-121 2.8e-07 2.0e-02 5.8e-20 2.1e-02 5.8e-03 9.9e-01
rs6430538 CCNT2-AS1 1.3e-04 9.5e-06 2.3e-02 5.4e-01 4.5e-01 6.8e-05 1.8e-01 4.4e-01
rs715 CPS1 1.4e-228 5.5e-02 3.6e-02 1.5e-03 3.0e-08 2.0e-01 3.5e-04 5.1e-01
rs6449202 SLC2A9 1.3e-05 1.3e-01 1.5e-04 5.3e-01 2.9e-01 3.7e-26 3.4e-01 3.9e-01
rs11950562 SLC22A4 2.6e-34 7.3e-01 7.5e-02 2.0e-01 6.9e-16 3.2e-01 8.1e-01 6.2e-05
rs4074995 RGS14 4.7e-04 6.3e-03 5.2e-04 4.6e-01 9.2e-02 1.0e-02 4.4e-05 1.6e-01
rs1179087 SLC17A3 1.0e-03 6.1e-01 3.2e-04 5.7e-01 2.6e-04 4.6e-04 1.7e-01 2.7e-01
rs657152 ABO 1.2e-04 5.7e-03 8.7e-02 1.0e-04 1.4e-01 2.0e-03 1.3e-26 1.1e-01
rs964184 ZPR1 4.6e-02 8.2e-05 6.9e-04 6.4e-03 9.1e-20 5.0e-02 1.1e-01 6.5e-01
rs11045819 SLCO1B1 8.5e-04 8.0e-01 3.6e-04 1.5e-01 2.0e-38 6.9e-02 9.1e-01 1.7e-02
rs4149056 SLCO1B1 3.1e-04 5.6e-01 4.8e-04 8.3e-01 3.3e-142 2.4e-01 6.5e-01 8.4e-01
rs2062541 ABCC1 7.1e-05 2.1e-01 8.8e-01 1.7e-14 2.9e-08 4.4e-01 1.1e-06 9.0e-01
rs310331 ZNF19 5.9e-04 9.7e-01 6.4e-04 5.9e-01 3.9e-01 1.0e-01 1.3e-05 1.4e-01
rs7225637 CCDC57 3.1e-10 8.7e-02 6.7e-02 4.2e-06 1.3e-05 8.3e-01 9.4e-01 4.4e-01
Table S2: Metabalics GWAS data analysis: significant SNPs at r = 3 after clumping (r2 set to 0.1
in PLINK). Individual p-value for each of the 8 super-pathways are shown. The significant ones
for each marker are in bold. FDR controlled at α = 0.05.
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Figure S1: Comparison of expected number of false discoveries E(V ) (PFER). The dotted line
indicates the nominal level α = 1. The error bars are the 95% CI of estimated PFER.
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Figure S2: Comparison of power (recall or sensitivity) when PFER is controlled at α = 1. The
error bars are the 95% CI of the recall for B = 100 experiments. b = 100 is the weak dependence
scenario and b = 1000 is the strong dependence scenario.
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Figure S3: Comparison of false discoveries rate E(V/R) (FDR). The dotted line indicates the
nominal level α = 0.2. The error bars are the 95% CI of estimated FDR.
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Figure S4: Comparison of power (recall or sensitivity) when FDR is controlled at level α = 0.2.
The error bars are the 95% CI of the recall for B = 100 experiments.
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Figure S5: Histogram of the individual p-values for each of the DMD datasets. The spike at 1 is
due to the reason that we use Bonferroni combination rule to get a combined p-value when multiple
probe-sets are referring to the same gene.
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Figure S6: Correlation of test statistics of the m = 275 metabolites. The darker the color, the
higher the absolute value of the correlation. The metabolite measurements are reordered so that
metabolites in the same pathway are adjacent to each other. The red lines and blue texts label the
eight super-pathways.
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Figure S7: AdaFilter Bonferroni procedure. On the x-axis, indexes j of the hypotheses, ordered in
increasing values of the filtering p-values: F(1) ≤ · · · ≤ F(M). On the y-axis, filtering and selection
p-values for each of the hypotheses: F(j) are plotted with filled triangles, and Sj∗ with crosses where
j∗ is the true index of F(j). The solid green line is the α/j boundary, and the color blue is used
to indicate hypotheses that pass the filtering step, while the red circle marks hypotheses that pass
the selection step. The left and right panels represent two possible definitions of m.
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